Evidence map›Paper›PMID 31324985›Full record

ArticleExtremophiles : life under extreme conditions2020

Isolation and characterization of violacein from an Antarctic Iodobacter: a non-pathogenic psychrotolerant microorganism.

Joaquin Atalah, Lotsé Blamey, Sebastian Muñoz-Ibacache, Felipe Gutierrez, Marcela Urzua, Maria Victoria Encinas, Maritza Páez, Junsong Sun, Jenny M Blamey

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Extremophiles : life under extreme conditions, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Multiple Adaptive Strategies of HimalayanFrontiers in microbiology · 2022
    Article
  5. Review
  6. Multi-target drug with potential applications: violacein in the spotlight.World journal of microbiology & biotechnology · 2021
    Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Joaquin AtalahFundación Biociencia, José Domingo Cañas 2280, Ñuñoa, Santiago, Chile.
Lotsé BlameyFundación Biociencia, José Domingo Cañas 2280, Ñuñoa, Santiago, Chile.
Sebastian Muñoz-IbacacheFundación Biociencia, José Domingo Cañas 2280, Ñuñoa, Santiago, Chile.
Felipe GutierrezDepartamento de Ingeniería Química, Universidad de Santiago de Chile, Alameda 3363, Estación Central, Santiago, Chile.
Marcela UrzuaDepartamento de Química, Facultad de Ciencias, Universidad de Chile, Las Palmeras 3425, Ñuñoa, Chile.
Maria Victoria EncinasFacultad de Química y Biología, Universidad de Santiago de Chile, Alameda 3363, Estación Central, Santiago, Chile.
Maritza PáezDepartamento de Química de los Materiales, Universidad de Santiago de Chile, Alameda 3363, Estación Central, Santiago, Chile.
Junsong SunLaboratory of Biorefinery, Shanghai Advanced Research Institute, Haike Rd. 99, Pudong, Shanghai, 201210, People's Republic of China.
Jenny M BlameyFundación Biociencia, José Domingo Cañas 2280, Ñuñoa, Santiago, Chile. jblamey@bioscience.cl.
Universidad de Santiago de Chile · CLFundación Chile · CLShanghai Advanced Research Institute · CNUniversity of Chile · CL

Funding

THE FREEZING OF MULTICELLULAR SYSTEMSF06TW001412 · FIC · UNIVERSITY OF TEXAS AUSTIN · PI DILLER, KENNETH R · 1988 to 1988
–
Comisión Nacional de Investigación Científica y Tecnológica PIA ACT1412Sino-Chile International Scientific Cooperation Project Scientific Cooperation Project 2019
6 · The paper itself

Abstract

Violacein is an intensely purple pigment synthesized by various genera of bacteria that has been discovered to have a wide range of interesting biological activities which range from anticarcinogenic to antibacterial. One of the hindrances for its real-life application is that the first microorganisms found to produce the compound may act as opportunistic pathogens. Here, we report the isolation and characterization of violacein from a non-pathogenic Antarctic Iodobacter strain. Its anti-microbial properties were also tested. The method proposed here for the purification of violacein shows high yields, indicating that this Antarctic microorganism could be a valuable source for this important pigment. This is the first characterization of violacein from an Antarctic Iodobacter strain and here we also present a viable method to obtain this pigment for potential biotechnological applications.

Indexed as

BetaproteobacteriaAntarctic RegionsBacteriaIndolesIndolesviolaceinAntarctic microbiologyIodobacterNatural compoundsPigmentViolacein

Identifiers

PMID31324985
OpenAlexW2963422463

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.